| 2023 | | A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma—From m6A Modification to Blood Biomarkers | 은정우, 정재연 |
| 2024 | | Anti-TCP1 Antibody Is a Potential Biomarker for Diagnosing Systemic Lupus Erythematosus | 강호철, 백욱영, 서창희, 정주양 |
| 2022 | | Artificial Intelligence-Powered Whole-Slide Image Analyzer Reveals a Distinctive Distribution of Tumor-Infiltrating Lymphocytes in Neuroendocrine Neoplasms | 김석휘 |
| 2023 | | Association of eosinophil-derived neurotoxin levels with asthma control status in patients with aspirin-exacerbated respiratory disease | 박해심, 예영민 |
| 2019 | | Biomarkers for adult-onset still's disease: up-to-date | 김현아 |
| 2015 | | Biomarkers for systemic lupus erythematosus: an update | 김현아, 서창희, 정주양 |
| 2018 | | Blood eosinophil count as a prognostic biomarker in COPD | 박주헌, 이규성, 황성철 |
| 2020 | | Changes of the clinical and serum biomarkers after anti-IL-5 antibody treatment in patients with severe eosinophilic asthma | 박해심, 장재혁 |
| 2018 | | Characteristic patterns of HLA presentation and T cell differentiation in adult-onset Still's disease | 김현아, 서창희, 손성향, 정주양 |
| 2013 | | Decreased Metabolism in the Cerebral Cortex in Early-Stage Huntington's Disease: A Possible Biomarker of Disease Progression? | 이수진 |
| 2016 | | Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up | 정재연, 조효정 |
| 2020 | | Estimated Association Between Cytokines and the Progression to Diabetes: 10-year Follow-Up From a Community-Based Cohort | 조남한 |
| 2018 | | Expression of EpCAM in adenoid cystic carcinoma | 권지은 |
| 2020 | | HIP1R Expression and Its Association with PD-1 Pathway Blockade Response in Refractory Advanced NonSmall Cell Lung Cancer: A Gene Set Enrichment Analysis | 고영화, 이현우, 한재호, 함석진 |
| 2014 | | Identification of DNA Copy Number-Dependent Transcriptional Deregulation inHepatocellular Carcinoma (HCC) | 권소미, 백은주, 우현구 |
| 2019 | | Increased CMTM6 can predict the clinical response to PD-1 inhibitors in non-small cell lung cancer patients | 고영화, 이현우, 정준호, 한재호, 함석진 |
| 2023 | | Increased Immunoglobulin Gamma-3 Chain C in the Serum, Saliva, and Urine of Patients with Systemic Lupus Erythematosus | 김지원, 김현아, 백욱영, 서창희, 정주양 |
| 2023 | | Long-term clinical outcomes of aspirin-exacerbated respiratory disease: Real-world data from an adult asthma cohort | 박래웅, 박해심, 이영수 |
| 2018 | | Polyamine patterns in plasma of patients with systemic lupus erythematosus and fever | 김현아, 서창희, 이광, 정주양 |
| 2022 | | Predictive Biomarkers of the Exacerbation-prone Phenotype in Adult Asthmatics: Multi-dimensional Analyses of Real-world Clinical Practice | 박해심, 우성대 |
| 2022 | | Promising Blood Biomarkers for Clinical Use in Alzheimer’s Disease: A Focused Update | 문소영, 박선아, 이선민 |
| 2020 | | Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma | 김순선, 은정우, 정재연, 조효정 |
| 2019 | | Serum level of eosinophil-derived neurotoxin: a biomarker for asthma severity in adult asthmatics | 박해심, 이영수 |
| 2020 | | Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma | 김순선, 은정우, 정재연, 조효정 |
| 2019 | | The levels of CXCL12 and its receptor, CXCR4, as a biomarker of disease activity and cutaneous manifestation in adult-onset Still's disease | 권지은, 김현아, 서창희, 임현이, 정주양, 한재호 |
| 2019 | | The role of damage-associated molecular pattern for pathogenesis and biomarkers in adult-onset Still's disease | 김현아, 서창희, 정주양 |
| 2015 | | TLR4 endogenous ligand S100A8/A9 levels in adult-onset Still’s disease and their association with disease activity and clinical manifestations | 김현아, 서창희 |
